sequencing with cabozantinib in advanced hcc
Published 5 years ago • 236 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
7:29
understanding how best to sequence in advanced hcc
-
0:54
dr. singal on the fda approval of cabozantinib in hcc
-
1:36
cabozantinib in patients with hcc refractory to checkpoint inhibitors
-
6:00
clinical rationale for cabozantinib in hcc
-
2:33
celestial trial: second-line cabozantinib’s value in hcc
-
1:18
dr. abou-alfa on the fda approval of cabozantinib in hcc
-
7:57
optimizing sequencing of therapies in hcc
-
1:08
dr. abou-alfa on sequencing agents in the treatment of patients with hcc
-
3:56
comparative efficacy of cabozantinib and regorafenib for advanced hepatocellular carcinoma
-
1:37:24
evidence-based treatment selection and sequencing in advanced hcc
-
8:40
advanced hcc: celestial trial
-
1:06
dr. huey on sequencing sorafenib among novel combos in hcc
-
6:39
emerging second-line therapies in hcc
-
5:48
second-line therapy in advanced hcc
-
9:48
emerging novel combinations in advanced hcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
1:34
dr. eric sherman on the sequencing of cabozantinib and vandetanib for mtc
-
5:56
the rationale for cabozantinib in advanced rcc
-
5:19
lenvatinib and cabozantinib in renal cell carcinoma